Negative chronotropic effect of endothelin-1 (ET- 1) in the cardiac pacemaker tissue

Journal of Physiology and Pharmacology

Volumn 54, Issue 1, 2003, Pages 53-63

  Goraca A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Endothelin receptors blocker; Endothelin 1; Pacemaker tissue

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 1 [11-21]; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ISOPRENALINE; JKC 301; PRAZOSIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART RIGHT ATRIUM; NEWBORN; NONHUMAN; RAT; SINUS NODE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOTONIC AGENTS; DEPRESSION, CHEMICAL; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; HEART ATRIA; HEART RATE; ISOPROTERENOL; OLIGOPEPTIDES; PRAZOSIN; RATS; RECEPTORS, ENDOTHELIN;

EID: 0037347763     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Inoue A, Yanagisawa M, Kimura S, Kasauya Y, Miyauchi T, Goto K, and Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U.S.A. 1989; 86: 2863-2867.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
3. Suzuki T, Kumazaki T, Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 1993; 191: 823-830.
4. Walch L, Norel X, Gascard JP, Brink C. Cysteinyl-leukotriene receptors in pulmonary vessels. J Physiol Pharmacol 1999; 50: 567-573.
5. Ohta M, Pai R, Kawanaka H, Ma T, Sugimachi K, Sarfeh IJ, Tarnawski AS. Expression of endothelin-1, and endothelin A and B receptors in portal hypertensive esophagus of rats. J Physiol Pharmacol 2000; 51: 57-67.
6. Josko J, Hendryk S, Jedrzejewska-Szypulka H, Słowiński J, Gwozdz B, Lange D, Harabin-Slowinska M. Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats. J Physiol Pharmacol 2000; 51: 241-249.
7. Josko J, Hendryk S, Jedrzejewska-Szypulka H, Słowiński J, Gwozdz B, Lange D, Snietura M, Zwirska-Korczala K, Jochem J. Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockade with BQ-123 antagonist in rats. J Physiol Pharmacol 2001; 52: 237-248.
8. Ito H., Hirata Y., Hiroe M., Tsujino M., Adachi S., Takamoto T., Nitta M., Taniguchi K., Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytcs. Cic Res 1991; 69: 209-215.
9. B receptors and ECE and distribution of endothelin-1 in failing rat heart. Am J Physiol 1999; 276 (Heart Circ Physiol 45): H1197-H1206.
10. Stawski G., Olsen U.,B., Grande P. Cytoxic effect of endothelin -1 during "stimulated" ischaemia in cultured rat myocytes. Eur J. Pharmacol 1991; 201: 123-124.
11. Clozel J,P, Clozel M. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 1989; 65: 1193-1200.
12. Ezra D, Goldstein RE, Czaja JF, Feuerstein GZ. Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol 1989; 257: H339-H343.
13. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation: implication for vascular function. Circulation 1991; 84: 457-468.
14. Moravec CS, Reynolds EE, Stewart RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun. 1989; 159: 14-18.
15. Takanashi M, Endoh M. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 1991; 261: H611-H619.
16. Shah AM, Lewis MJ, Henderson AH. Inotropic effects of endothelin in ferret ventricular myocardium. Eur J Pharmacol 1989; 163: 365-367.
17. MacCarthy PA, Grocott-Mason R, Prendergast BD, Shah AM. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET (A) receptor antagonist. Circulation 2000; 101: 142-147.
18. Geller L, Merkey B, Szokobi I, Szabo T, Vecsey T, Juhasz-Nagy A, Toth M, Horkay F. Electrophysiological effects of intrapericardial infusion of endothelin-1. Pace 1998; 21 (part II): 1510156.
19. Arai H, Hori S, Aramori I, Onkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732.
20. Sakurai T, Yanagisawa M, Takuwa Y, miyazaki H, Kimura S, Goto K, Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732-735.
21. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 1993; 72: 526-538.
22. Zhu Y, Yang HT, Endoh M. Negative chronotropic and inotropic effects of endothelin isopeptides in mammalian cardiac muscle. Negative chronotropic and inotropic effects of endothelin isopeptides in mammalian cardiac muscle. Am J Physiol 1997; 273 (Heart Circ Physiol 42): H119-H127.
23. Suzuki M, Ohte N, Wang ZM, Wilhans DL Jr, Little WC, Cheng CP. Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy. Cardiovasc. Res 1998; 39: 589-599.
24. Gora̧ca A. Increase in vasopressin concentration and cardiodepressant activity in the blood dialysates after NMDA and hypertonic saline administration. J Physiol Pharmacol 1998; 49: 561-575.
25. Ono K, Masumiya H, Sakamoto A, Christe G, Shjuku T, Tanaka H, Shigenobu K, Ozaki Y. Electrophysiological analysis of the negative chronotropic effect of endothelin-1 in rabbit sinoatrial node cells. J Physiol 2001; 537 (Pt 2): 467-488.
26. Grossman ID, Morgan JP. Cardiovascular effects of endothelin. News Physiol Sci 1997; 12: 113-117.
27. Kramer BK, Smith TW, Kelly RA. Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C-dependent Na+H+ exchanger. Circ Res 1991; 68: 269-279.
28. + exchange is impaired in cardiac hypertrophy. J Clin Invest 1997; 99: 125-135.
29. 2+ signaling in rabbit ventricular myocytes. Br J Pharmacol 2000; 131: 638-644.
30. Beyer ME, Slesak G, Hovelborn T, Kazamaier S, Nerz S, Hoffmeister HM. Inotropic effects of endothelin-1: interaction with molsidomine and with BQ 610. Hypertension 1999; 33: 145-152.
31. Pi Y, Sreekumar R, Huang X, Walker JW. Positive inotropy mediated by diacylglyerol in rat ventricular myocytes. Circ Res 1997; 81: 92-100.
32. 2+ current in rabbit ventricular myocytes. Naunyn- Schmiedebergs Arch Pharmacol 1999; 360: 654-664.
33. Brehm BR, Heinle H, Risler T, Wolf SC. Chronically elevated endothelin-1 concentrations modulate the beta-adrenergic receptor system in vitro and in vivo. J Cardivasc Pharmacol 2000; suppl. 1: 157-159.
34. Tsai CS, Cheng TH, Lin CL, Chen JJ, Lee FY, Li Cy, Hong HJ, Loh SH. Inhibitory effect of endothelin-1 on the isoproterenol-induced chloride current in human cardiac myocytes. Eur J Pharmacol 2001; 424: 97-105.
35. Walker CA, Ergul A, Grubbs A, Zile MR, Zellner JL, Crumley Aj, Spinale FG. Beta-Adrenergic and endothelin receptor interaction in dilated human cardiomyopathic myocardium. J Card Fail 2001; 7: 129-137.
36. Banyasz T, Magyar J, Kortvely A, Szigeti G, Szigligeti P, Papp Z, Mohacsi A, Kovacs L, Nanasi PP. Different effects of endothelin-1 on calcium and potassium currents in canine ventricular cells. Naunyn-Schmiedebergs Arch Pharmacol 2001; 363: 383-390.
37. 2+ current in dog ventricular myocytes. J Cardiovasc Pharmacol 2000; 36: 344-350.
38. Zhu Y, Yang HT, Endoh M. Does nitric oxide contribute to the negative chronotropic and inotropic effects of endothelin-1 in the heart? Eur J Pharmacol 1997; 332: 195-199.
39. Schmetter L, Dallinger S, Polak K, Eichler HG, Wolzt M. Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man. Nitric Oxide 1999; 3: 209-215.
40. Crockett TR, Scott GA, McGowan NW, Kane KA, Wainwright CL. Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists BQ-123 and PD 1611721. Eur J Pharmacol 2001; 432: 71-77.
41. Gardiner SM, March JE, Kemp PA, Bennett T. Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious hypertensive ((mRen-2)27) rats. Br J Pharmacol 2000; 131: 1732-1738.
42. 2+ signaling in guinea pig ventricular myocytes: role of protein kinase C. J Mol Cell Cardiol 1999; 31: 631-643.